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Focal segmental glomerulosclerosis (FSGS) is a potential cause of ne-
phrotic syndrome both in humans and pet mammals. Glomerulopathy was report-
ed earlier in green fluorescent protein (GFP) transgenic (TG) mice, but glomeru-
losclerosis has not been examined in GFP TG rabbits so far. In the present study, 
the potential manifestation of FSGS was investigated in both Venus TG rabbits 
generated by Sleeping Beauty (SB) transposition and age-matched control New 
Zealand White (NZW) rabbits. Venus protein fluorescence was detected by con-
focal microscopy and quantified by microplate reader. Urinalysis, haematology, 
serum biochemistry and renal histology were performed to assess the signs of 
FSGS. Higher levels of Venus fluorescence were determined in renal cortex sam-
ples than in the myocardium by both methods. Urinalysis revealed proteinuria in 
Venus heterozygote TG bucks, while Venus homozygote TG bucks developed 
microscopic haematuria. Supporting the urinalysis data, the histological findings 
of FSGS (glomerulomegaly and sclerotic glomeruli) were observed in renal cortex 
sections of Venus TG rabbits. Taken together, Venus TG bucks were diagnosed 
with FSGS; thus, this type of glomerulopathy could be a common disease in TG 
animals overexpressing GFP. 
Key words: Focal segmental glomerulosclerosis, transgenic rabbits, uri-
nalysis  
Focal segmental glomerulosclerosis (FSGS) is a chronic renal disease and 
the most frequent glomerular disorder which may cause end-stage renal disease 
in humans (D’Agati et al., 2011). The main signs of FSGS are marked pro-
teinuria and podocyte injury. FSGS was first identified in 1970 as a separate his-
topathological entity (Churg et al., 1970). FSGS can be primary (the initial cause 
is not known) or secondary (e.g. obesity- or drug-induced, virus infection-
associated, etc). Approximately 80% of FSGS cases are primary with poor sensi-
tivity to steroid treatment (D’Agati et al., 2011). Clinical investigations demon-
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strated that men have a worse outcome than women in the severity and progres-
sion of FSGS; this male predominance was also observed in laboratory animals 
(Kummer et al., 2012). For a better understanding of the underlying mechanism, 
transgenic (TG) rodent models for FSGS were established (Hocher et al., 1997; 
Michaud et al., 2003). Green fluorescent protein (GFP) TG mice also had renal 
abnormalities which led to glomerulosclerosis (Guo et al., 2007). In another re-
port, more severe proteinuria and higher numbers of sclerotic glomeruli were ob-
served in a GFP TG mouse strain after doxorubicin treatment compared with 
non-TG mice (Takagi-Akiba et al., 2012). 
FSGS may also occur in pet mammals, e.g. dogs, cats and rabbits (Hinton, 
1981; Khan and Khan, 2015). In experiments involving surgical methods, rabbits 
are a better choice than mice due to their larger organs; thus, the development 
and characterisation of TG rabbit FSGS models could be useful in veterinary 
medicine. 
Here we report the assessment of FSGS in TG rabbits generated by Sleep-
ing Beauty (SB) transposition expressing the Venus protein (Katter et al., 2013). 
The Venus transgene integrated into the rabbit genome in one monomeric copy at 
chromosome 8. The genomic region of the Venus TG construct has been updated 
recently, and the transgene was located in the intron 12–13 of the diaphanous re-
lated formin 3 gene (DIAPH3, Ensembl gene ID: ENSOCUG00000001719). Be-
sides looking for the signs of FSGS (sclerotic glomeruli, proteinuria, haematu-
ria), the possible presence of underlying disorders (obesity, dilated cardiomyopa-
thy, polycythaemia vera) was also examined. Heart-specific GFP expression 
caused dilated cardiomyopathy in TG mice (Huang et al., 2000), which cardiac 
disease may be associated with FSGS (Adedoyin et al., 2004). 
Using Venus TG rabbits bred and tested for homozygosity, we could test 
the hypothesis whether higher fluorophore expression causes more severe signs 
in Venus homozygote TG compared to heterozygote TG rabbits. Venus protein is 
a yellow shifted variant of the GFP (Shimomura et al., 1962). Its expression is 
driven by the constitutive cytomegalovirus enhancer and chicken beta actin pro-
moter (CAGGS). Transgene silencing was not observed throughout four genera-
tions of the TG line. As in Venus TG pigs (Garrels et al., 2011), reduced litter 
size or adverse effects of Venus expression on fecundity were not observed in 
TG rabbits (Liptak et al., 2017). In our previous study, robust expression of Ve-
nus protein in all organs was demonstrated in a male founder by fluorescence 
microscopy (Katter et al., 2013). 
Although there are published observations about glomerulosclerosis in en-
hanced green fluorescent protein (EGFP) TG mice, the possible manifestation of 
FSGS in CAGGS-GFP TG rabbits (Takahashi et al., 2007) or in other EGFP TG 
non-mouse species has not been examined yet. The aim of the present study was 
to clarify whether TG rabbits with ubiquitous fluorophore expression had a glo-
merular disorder similar to that reported previously in EGFP TG mice. 
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Materials and methods 
Ethics statement 
All experiments were approved by the Animal Care and Ethics Committee 
of the NARIC Agricultural Biotechnology Institute and the government office of 
Pest County (permission numbers: PEI/001/329-4/2013 and PEI/01/857-3/2015). 
The experiments complied with the Hungarian Code of Practice for the Care and 
Use of Animals for Scientific Purposes, including the conditions for animal wel-
fare and handling prior to slaughter.  
Animals 
Venus TG and wild-type NZW bucks (age: 4–5 months) were used for in-
vestigating the main signs of FSGS. Besides one control and two Venus TG het-
erozygote bucks, an additional 8-month-old Venus homozygote TG buck was al-
so tested for signs of obesity and dilated cardiomyopathy. Venus homozygote 
TG rabbits were crossed to obtain homozygote TG; while wild-type ♀ X Venus 
heterozygote TG ♂ mating resulted in Venus heterozygote TG and wild-type off-
spring. In line with our previous observations, Venus TG newborns exhibited 
macroscopic Venus specific fluorescence under UV light illumination, while 
non-TG rabbits remained Venus negative (Katter et al., 2013). Additionally, all 
offspring were tested for the presence of the Venus transgene using standard pol-
ymerase chain reaction (PCR). The animals were kept under a standard light–
dark cycle in the same animal house (lights on between 07:00 a.m. and 07:00 
p.m.) at 18 ± 3 °C with food and water available ad libitum and caged separately. 
Blood sample collection and analysis 
Peripheral blood samples were obtained into K3-EDTA containing tubes 
(Microvette, Sarstedt, Germany) from the ear arteries of rabbits (Jenkins, 2008). 
Blood sampling was performed between 01:00 and 02:00 p.m. to avoid fluctua-
tions caused by circadian rhythm. Parameters were counted by an Abacus Junior 
Vet5 haematology analyzer. Differential leukocyte counts were evaluated by 
counting 100 cells in blood smears stained with Diff-Quick. 
Serum biochemistry (creatinine, albumin, cholesterol and triglycerides, 
Vacutainer serum tubes) was also performed in four rabbits (one wild type, two 
Venus heterozygote TG and one Venus homozygote TG). 
Urinalysis 
After blood sample collection, rabbit urine samples (2–5 ml) were ob-
tained with gentle bladder expression under anaesthesia (Melillo, 2007) with the 
combination of Ketamidor (Richter Pharma AG, Hungary) and Xylazine (CP-
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Pharma, Germany, IV). Total protein (TP, g/L) and creatinine (Crea, g/L) con-
centrations in the urine supernatant; the number of leukocytes and red blood cells 
(RBCs) per high power field (HPF) in the sediment were measured as the param-
eters of proteinuria and haematuria. The TP (g/L) concentration of urine superna-
tants (20 µl from each sample) were estimated by the pyrogallol red–molybdate 
method with a clinical chemistry analyzer (Olympus AU400, Olympus Diagnos-
tica, Germany). The total protein ultrasensitive kit (Diagnosticum Inc., Hungary) 
was used for the colorimetric measurements. TP/Crea ratio under 0.6 (Melillo, 
2007), TP (g/L) under 1 g/L and maximum 3 RBCs in the sediment (Jenkins, 
2008) were accepted as normal. TP concentrations between 1–3 g/L were defined 
as mild, and those above 3 g/L as severe proteinuria (Matsuo et al., 1987). The 
supernatants of urine samples were also tested for the presence of glucose, ke-
tone, haemoglobin and protein. 
Detection and measurement of Venus expression in heart and kidney samples 
Venus expression in the glomeruli and myocardium were visualised by 
confocal microscopy. Nuclei were stained with propidium iodide (Molecular 
Probes, Invitrogen, UK) and mounted with FluorSave reagent (Merck Millipore, 
USA). The images of the sections were obtained with a Leica TCS SP8 confocal 
microscope equipped with PMT (gain 550 V) detector. The detection range of 
the Venus channel was 510–570 nm, while the propidium iodide staining was 
recorded at 580–700 nm. 
Venus fluorescence was quantified by a microplate reader (Hidex Cameleon 
2000, Finland). Tissue samples were prepared according to the manufacturer’s 
instructions (GFP Quantitation kit, Cell Biolabs, Inc., USA). Same-amount tissue 
samples were homogenised with 500 µl 1× lysis buffer, then the tissue lysates 
were centrifuged for 5 min at 13,000 rpm. The supernatants (100 µl) were trans-
ferred to a 96-well plate and their fluorescence was recorded at 485/535 nm. 
Each sample was assayed in duplicate. 
The Venus protein concentrations of the tissue samples were calculated 
according to following equation: 
(Fluosample / FluoGFP.standard) × CGFP.standard = Csample 
where Fluo is the fluorescence and C is the concentration. 
Histology and gross pathology examination 
After urine and blood sampling, the rabbits were sacrificed; the heart and 
kidneys were removed, washed in PBS, and then fixed in 4% (w/v) PFA at 4 °C 
for 24 h. Tissue samples for histology were replaced in the cryoprotective 30% 
(w/v) sucrose–PBS solution at 4 °C for 24 h. The samples were embedded into 
cryomedium before cryosectioning (Cryomatrix, Thermo Scientific, USA) and cut 
into 10 µm thick sections on a cryostat (Microm, Germany) for confocal imaging. 
 GLOMERULOPATHY IN TRANSGENIC RABBITS 285 
Acta Veterinaria Hungarica 66, 2018 
Haematoxylin and eosin (HE) staining was performed on paraffin-
embedded renal cortex and myocardium sections (Haemalum and eosin Y solu-
tion, Carl Roth GmbH, Germany). Renal cortex sections were also stained with 
Periodic acid–Schiff (PAS) solutions for further evaluation of glomerular mor-
phology (Periodic acid solution 1% and Schiff’s reagent, Carl Roth GmbH, 
Germany). Fifty glomeruli from the entire renal cortex of each rabbit were exam-
ined for glomerulosclerosis. Glomeruli were taken as sclerotic if the mesangial 
expansion was more than 30% in the glomerular area (Kimura et al., 1991). After 
staining, sections were mounted with DPX (Fluka, Germany). Myocardium sec-
tions were studied for the presence of changes indicative of dilated cardiomyopa-
thy (vacuolisation, granulation, necrosis and interstitial fibrosis (Gava et al., 
2013). Tissue sections of each rabbit were analysed by light microscopy [Olym-
pus BH2 (BH4), Germany] and photographed with a smartphone (Samsung Elec-
tronics, South Korea). 
In the case of four rabbits (one wild type, two Venus heterozygote TG and 
one Venus homozygote TG), gross examination of the heart and kidneys was al-
so performed. After fixation, kidneys and hearts were halved and the gross mor-
phology was analysed with the naked eye. Heart and kidney mass/body mass ra-
tios (g/kg) were also calculated. 
Statistical analysis 
Statistical analyses were performed by one-way ANOVA followed by 
Tukey post-hoc test using PSPP Statistical Analysis Software 0.8.4. A probabil-
ity value of P < 0.05 was considered statistically significant. 
 
 
Results 
Complete blood count and serum biochemistry 
Complete blood counts were within the normal reference ranges in all 
groups (data not shown). Serum cholesterol levels were slightly elevated in the 
Venus TG bucks (heterozygote: 0.9 and 1.6 mmol/L, respectively; homozygote: 
1.7 mmol/L) compared to the control buck (0.7 mmol/L), but serum parameters 
of all rabbits were within the normal reference ranges. 
Urinalysis 
The urine supernatants of all rabbits were negative for glucose, ketone and 
haemoglobin with normal pH. The supernatants of control bucks were also nega-
tive for protein, while the samples of 6 Venus TG bucks (4 heterozygote, 2 ho-
mozygote) were found to be positive for protein by the sulphosalicylic acid test. 
TP/Crea ratio in Venus TG heterozygote bucks was significantly higher com-
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pared with the control bucks (see statistics in Table 1). The urine sediment of 
Venus heterozygote TG and control rabbits contained RBCs and leukocytes 
within normal ranges. Two out of five Venus homozygote TG bucks developed 
microscopic haematuria (15 and 30 RBCs/HPF, respectively). 
Table 1 
Proteinuria and microscopic haematuria in Venus transgenic (TG) bucks 
Groups 
Non-TG  
control 
(n = 6) 
Venus TG  
heterozygote 
(n = 6) 
Venus TG  
homozygote 
(n = 5) 
Proteinuria (sulphosalicylic acid test) not detected in 4 bucks in 2 bucks 
Microscopic haematuria not detected not detected in 2 bucks 
TP (g/L)  0.38 ± 0.51 1.88 ± 1.58 0.45 ± 0.29 
TP/Crea ratio  0.29 ± 0.23 1.79 ± 1.61* 0.43 ± 0.34 
TP: total protein; Crea: creatinine. The mean value of TP/Crea in Venus TG heterozygote bucks 
was significantly higher compared to controls. TP (g/L) ratio was also elevated in Venus TG heter-
ozygote bucks, but not significantly compared with the control group (P = 0.052). Data are pre-
sented as mean ± SD. Asterisk denotes significant differences: TP/Crea ratio: *F(2.14) = 4.12, P = 
0.049 compared with control bucks, respectively 
 
Venus protein expression in histological sections and tissue samples 
The fluorophore expression in the renal cortex and myocardium of Venus 
TG and control rabbits was visualised by confocal microscopy (Fig 1a–f). Venus 
homozygote TG bucks showed stronger Venus protein expression in both tissues 
than Venus heterozygote TG bucks. Venus fluorescence was stronger in the renal 
cortex (Fig 1b–c) than in the myocardium (Fig 1e–f). The sections of control 
rabbits were Venus negative (Fig. 1a, d). 
Higher Venus protein concentration was determined in tissue lysates ex-
tracted from renal cortex samples than in those from the myocardium. The tissue 
lysates of Venus homozygote TG rabbits displayed higher levels of fluorescence 
than those of Venus heterozygote TG rabbits (see data in Table 2). 
Histology and gross assessment 
Contrary to control rabbits, which showed normal glomerular histology 
(Fig. 2a, d), Venus TG bucks of both genotypes had sclerotic glomeruli (Fig. 2e–f) 
and their sclerotic glomeruli/50 glomeruli ratio was significantly higher than that 
of the control rabbits (see statistics in Table 3). Glomerulomegaly was observed 
for 4–5 glomeruli in the sections of Venus TG rabbits (Fig. 2b, c) (4 heterozy-
gote, 4 homozygote), but not in sections of wild-type rabbits. 
Intracytoplasmic vacuolisation was detected in the myocardium sections 
of a Venus homozygote TG buck, but other histological findings of dilated cardi-
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omyopathy (granulation, necrosis and interstitial fibrosis) were not observed in 
any of the Venus TG and non-TG rabbits (sections not shown). 
Venus TG (2 Venus heterozygote TG and 1 Venus homozygote TG) bucks 
(Fig. 3b–c) had slightly dilated left ventricle, but their ventricular walls were not 
thinner compared to the control buck (Fig. 3a). The fat deposits were larger in 
the renal pelvis and renal medulla of Venus TG rabbits than in the control (Fig. 
3d–f). 
Table 2 
Quantification of Venus protein concentration in tissue lysates 
Animals Non-TG control (n = 2) 
Venus heterozygote TG  
(n = 2) 
Venus homozygote TG 
(n = 2) 
Tissue 
lysates 
Renal  
cortex Myocardium 
Renal  
cortex Myocardium 
Renal  
cortex Myocardium 
Venus  
protein 
(µg/ml)  
 
0.52 ±  
0.02 
 
0.23 ±  
0.02 
 
85.79 ±  
2.07 
 
28.56 ±  
2.75 
 
137.34 ± 
17.74 
 
34.83 ±  
2.74 
Higher Venus protein concentration was observed in tissue samples of Venus homozygote TG 
bucks than in Venus heterozygote TG bucks. Renal cortex samples had greater Venus fluorescence 
than the myocardium in both Venus heterozygote TG and homozygote TG bucks. Only autofluo-
rescence was detected in the lysates of control bucks (mean ± SD) 
 
 
Discussion 
TG rabbits are laboratory animals widely used for modelling human dis-
eases, but experimental data about glomerular disorders in GFP TG rabbits have 
not been published yet. Glomerulopathy was observed in β-actin EGFP TG mice 
(Guo et al., 2007). Only TG mice with the highest EGFP expression in their 
glomeruli developed glomerulosclerosis; other TG strains with lower EGFP ex-
pression displayed normal renal morphology. Unfortunately, the C57BL/6- 
TG(CAG-EGFP)1Osb/J homozygote line was not examined due to the premature 
death of these mice (Guo et al., 2007); thus, the urinalysis data and renal histology 
of Venus homozygote TG rabbits and EGFP homozygote TG mice could not be 
compared. 
In the current study, the main signs of FSGS were studied in both Venus 
heterozygote and homozygote TG rabbits. 
The complete blood count gives important information about the general 
health status of rabbits. In a few cases, FSGS in humans may be associated with 
polycythaemia vera, which is a myeloproliferative disease with overproduction of 
RBCs, leukocytes and platelets (Okuyama et al., 2007). In our experiments, the 
complete blood counts of both Venus TG and control rabbits were normal, so pol-
ycythaemia vera as a potential basis of FSGS in Venus TG rabbits could be ruled out. 
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Proteinuria and/or haematuria as the main signs of FSGS were detected in 
Venus heterozygote TG and homozygote bucks, respectively (Table 1). Our TP 
(g/L) data of the control group are comparable with the previously published 
normal values of 18 weeks old NZW rabbits [0.33 ± 0.13 g/L (Tendron-Franzin 
et al., 2004)]. In the previous study using EGFP TG mice (3 to 29 weeks old), 
40% of the examined TG mice had elevated urinary albumin level, but contrary 
to Venus TG rabbits, this TG mouse strain was not haematuric (Guo et al., 2007). 
Robust fluorophore expression in the renal cortex of Venus heterozygote 
and homozygote TG rabbits was determined by confocal microscopy (Fig. 1. a–c) 
and microplate reader (Table 2). Sclerotic lesions, hyalinosis and glomerulomeg-
aly were observed in the sections of Venus TG bucks of both genotypes (Fig. 
2b–c and Fig. 2e–f, Table 3). In harmony with the data about glomerulosclerosis 
in CAGGS-EGFP mice (Guo et al., 2007), the overexpression of the fluorophore 
in the glomeruli was associated with the presence of FSGS in Venus TG bucks. 
This similarity suggests that this type of glomerulopathy might be a common 
problem in TG animals with ubiquitous GFP expression. 
Table 3 
Glomerular histology 
Groups Non-TG control (n = 6) 
Venus TG  
heterozygote 
(n = 6) 
Venus TG  
homozygote 
(n = 5) 
Sclerotic glomeruli/ 
50 glomeruli ratio (PAS) 
 
2.33 ± 1.51 
 
11.00 ± 3.74* 
 
10.00 ± 7.07* 
Glomerulomegaly (HE) not detected in 4 bucks in 4 bucks 
PAS: Periodic acid–Schiff (PAS); HE: haematoxylin and eosin. Asterisks denote significant differ-
ences. F(2.14) = 6.58, P = 0.01 Venus TG heterozygote vs. control bucks and P = 0.046 Venus ho-
mozygote TG compared to control bucks 
 
 
Glomerulomegaly is an enlargement of the glomeruli which could be 
caused by glomerular hypertrophy, hypertension and/or congenital oligome-
ganephronia (Fogo, 2015). Besides mild proteinuria, glomerulomegaly is early 
indicator of minimal change disease and FSGS (Fogo et al., 1990). Glomerulo-
megaly typically presents in the perihilar histological subtype of FSGS, which is 
an adaptive form of the disease in human patients (D’Agati et al., 2011). 
In a previous report, TG mice with cardiac-specific GFP expression had 
dilated cardiomyopathy (Huang et al., 2000). Venus TG rabbits did not develop 
all histological and morphological findings of dilated cardiomyopathy (Fig. 3a–c); 
thus, the lower fluorophore expression in the myocardium of Venus TG rabbits 
(Fig. 1d–f) compared to the GFP TG mice (Huang et al., 2000) may not be strong 
enough to provoke all signs of this cardiac disease. 
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The fat accumulation in the renal pelvis and renal medulla was more ex-
tensive in Venus TG rabbits than in the control (Fig. 3d–f). 
In summary, Venus TG bucks had mild proteinuria and/or microscopic 
haematuria and FSGS with normal complete blood count. Our data indicated that 
the appearance of glomerulosclerosis in TG animals expressing the reporter GFP 
or its variants (EGFP, Venus) is not limited to mice. 
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